Drugs For Erectile Dysfunction Market Size, Status and Global Outlook During 2021 to 2030; Eli Lilly and Company (NYSE:LLY), Pfizer Inc. (NYSE:PFE), Bayer AG

By: X herald

MarketInsightsReport has published a report titled Global Drugs For Erectile Dysfunction Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market.

The erectile dysfunction (ED) drugs market consists of sales of erectile dysfunction (ED) drugs and related services. Erectile dysfunction is the inability to achieve or keep up penile erection in men.

The global drugs for erectile dysfunction market was valued at about $4.28 billion in 2018 and is expected to grow to $5.18 billion at a CAGR of 4.9% through 2022.

The erectile dysfunction drugs market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. The North American market is the largest market for erectile dysfunction drugs and is expected to continue to be the largest market during the forecast period.

Click here to get the latest sample PDF copy of updated research 2021 before purchase
https://www.marketinsightsreports.com/reports/05072013642/drugs-for-erectile-dysfunction-global-market-report-2020-including-1-by-drugs-sildenafil-citrate-mirodenafil-vardenafil-2-by-end-users-hospital-pharmacies-retail-pharmacies-online-pharmacies-3-by-mode-of-administration-oral-topical-injections-covering-eli-lilly-and-co-pfizer-bayer-ag-dong-a-pharmaceutical-co-ltd-vivus/inquiry?mode=72&source=XH

Drastic increase in the number of chronic diseases drives the erectile dysfunction drugs market. Erectile dysfunction is mainly caused by chronic diseases resulting from sedentary lifestyle such as cardiovascular diseases, diabetes, obesity, and high blood pressure. According to WHO, prevalence of chronic diseases is expected to grow by 57% by the end of year 2020. Prevalence of chronic diseases increases the chances of erectile dysfunction among men, thereby driving the erectile dysfunction drugs market.

Patients suffering from erectile dysfunction do not seek treatment owing to factors such as lack of education, lack of awareness, strong religious beliefs, social taboo, and low socioeconomic status. These factors are responsible for the patients suffering from erectile dysfunction to reject or avoid the treatment. For example, a study conducted by Harlem Hospital in New York City in 2018 among 100 men reveled that more than 86% of the respondents did not have the knowledge that smoking causes erectile dysfunction. These factors restrain the growth of erectile dysfunction drugs market.

New drug delivery techniques such as the use of pellets and creams are being implemented by many companies in the erectile dysfunction drugs market. Pellets and creams will have more efficacy and performance in erectile dysfunction and these are also more effective and safer to use. These benefits from drug delivery techniques will increase the scope of erectile dysfunction drugs market. For example, in 2018, Apricus Biosciences entered into manufacturing cream called vitaros to treat erectile dysfunction.

Browse full report description with TOC
https://www.marketinsightsreports.com/reports/05072013642/drugs-for-erectile-dysfunction-global-market-report-2020-including-1-by-drugs-sildenafil-citrate-mirodenafil-vardenafil-2-by-end-users-hospital-pharmacies-retail-pharmacies-online-pharmacies-3-by-mode-of-administration-oral-topical-injections-covering-eli-lilly-and-co-pfizer-bayer-ag-dong-a-pharmaceutical-co-ltd-vivus?mode=72&source=XH

Scope

Markets Covered:
1) By Drugs: Sildenafil Citrate, Mirodenafil , Vardenafil 2) By End users: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By Mode of Administration: Oral, Topical, Injections

Companies Mentioned: Eli Lilly and Company (NYSE:LLY), Pfizer Inc. (NYSE:PFE), Bayer AG, Dong-A Pharmaceutical Co. Ltd, Vivus

Regions covered By Drugs For Erectile Dysfunction Market Report 2021 To 2030 are
North America (The United States, Canada, and Mexico), Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, and Others), Europe (Germany, France, UK, Italy, Russia, and Rest of Europe), Central & South America (Brazil, and Rest of South America), and Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa and Other)

Effect of the Drugs For Erectile Dysfunction market report is
– A comprehensive evaluation of all opportunities and risks in the market.
– Drugs For Erectile Dysfunction market current developments and significant occasions.
– A deep study of business techniques for the development of the market-driving players.
– Conclusive study about the improvement plot of the market for approaching years.
– Top to the bottom approach of market-express drivers, targets, and major littler scale markets.
– Favorable impressions inside imperative mechanical and publicize the latest examples striking the market.

Contact Us
Irfan Tamboli (Sales Manager) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on mediarelations@xherald.com.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.